Daniel Laneville

Daniel Laneville is an experienced professional in the oncology and pharmaceutical industries, currently serving as a Senior Clinical Oncology Specialist at Puma Biotechnology, Inc. since March 2023, with a focus on breast cancer treatment. Prior roles include Senior Oncology Account Manager at GSK, where the emphasis was on female pelvic malignancies, and Executive Clinical Oncology Specialist at AstraZeneca, contributing to the breast team. Daniel's extensive background also includes positions at Helsinn Group, Astellas Pharma, Merck, and Kraft Foods, covering critical care, urology, cardiology, and primary care sales. Daniel holds a degree in Business Administration and Management from the State University of New York College at Plattsburgh.